Mumbai Rains: Heavy rainfall lashed Mumbai on Monday, May 26, as monsoon arrived in the city, causing severe waterlogging and flooding at underground metro stations. Visuals on the internet showed ...

South Korean shipbuilder Samsung Heavy Industries said on Wednesday that two orders from Russia's Zvezda worth a total of 4.85 trillion won ($3.54 bi Monday, June 23, 2025 🔍 ...

BlackRock, the world’s largest asset manager, has acquired over $69.7 billion worth of Bitcoin through its iShares Bitcoin Trust (IBIT) ETF, representing over 3.25% of the total BTC supply.

Over 200 patients were dosed, and 365 enrolled in the Nex-Z MAGNITUDE trial, aiming for 765 by early 2027. Intellia plans BLA filing for NTLA-2002 in HAE by late 2026, with a U.S. launch targeted ...

ITP consists of 1-3 VTPs provided at 4-week intervals until achieving complete response (CR) or treatment failure on Primary Response Evaluation (PRE) visit. Primary endpoint is CR on endoscopic ...

Officially six weeks out from the 2025 MLB trade deadline, teams like the Atlanta Braves are starting to mull over their options. At 34-40, six games back in the NL Wild Card race, the Braves aren ...

That is the compromise scenario floated by Dan Favale of Bleacher Report in his blockbuster three-team trade proposal. Here is Favale’s trade proposal: San Antonio Spurs Receive : Kevin Durant ...

Merck & Co – known as MSD outside the US and Canada – has shared promising results from a late-stage study of its anti-PD-1 therapy Keytruda (pembrolizumab) in ovarian cancer. The phase 3 KEYNOTE-B96 ...

The tests occurred on May 28, 2025, with a third hot test of the Engine Power Head Test Article (PHTA) at Mahendragiri's Isro Propulsion Complex, validating ignition sequences and stable operation ...

Atacicept ORIGIN Phase 3 trial met the primary endpoint of reduction in proteinuria (UPCR) at week 36; participants receiving atacicept achieved a 46% reduction from baseline and 42% reduction ...

Each substudy consists of a Phase 2 and a Phase 3 part. During the Phase 2 part, pts will be randomized 1:1 to receive BNT327 at either 1400 mg (Arm 1) or 2000 mg (Arm 2) plus chemo (carboplatin + ...

NEWARK, Calif. & OSAKA, Japan & CAMBRIDGE, Mass., June 01, 2025--Protagonist Therapeutics, Inc. ("Protagonist") (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announced detailed results from the ...